Clinical Medicine Insights: Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2254583, encodeId=91582254583cd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：主编华人，对国人比较友好，主编和评审专家也非常负责，分不高，但也不水，希望期刊越办越好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Tue Mar 04 21:40:32 CST 2025, time=2025-03-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131524, encodeId=869021315241d, content=3.12投稿的，至今已2个月了，状态从未改变。有啥建议吗？可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu May 11 07:20:15 CST 2023, time=2023-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117027, encodeId=1973211e027d7, content=这个是纯开源的杂志吗，费用多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5026441235, createdName=ms1000000232937298, createdTime=Wed Mar 01 11:33:26 CST 2023, time=2023-03-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113822, encodeId=9602211382224, content=有人投过综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 09 17:10:11 CST 2023, time=2023-02-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1071848, encodeId=545710e184814, content=经验分享：历时2个月顺利接收，非常感谢网友老师的热心回复，很有帮助。我的经验也是借鉴的平台上前辈们的简易。中国本土医学研究的文章，在这个期刊的确比较容易接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=一转身的距离, createdTime=Fri Nov 19 19:22:28 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229142, encodeId=75bc122914263, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021.11转投，2022.5接受，中间返修2次，3个审稿人和编辑都比较负责。其中一个审稿人意见不好，但也给了argue的机会。虽然看到2021IF跌到1点分了，但还是希望杂志越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70392090263, createdName=1591f428e7m, createdTime=Tue Jun 28 13:33:48 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069851, encodeId=6f291069851dd, content=是的，这个期刊投中国的本土研究室比较容易投稿成功。8月中投了一篇，现在已经过了初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=LAH9, createdTime=Sat Nov 13 10:49:36 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203783, encodeId=d38e1203e83a8, content=为什么投稿后会被执行编辑退回呢？是格式不对吗？有知道的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Fri Mar 18 14:00:25 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195808, encodeId=11fe1195808fb, content=投了三个月都没有消息，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Mon Feb 21 20:02:22 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113668, encodeId=9477111366824, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2025-03-04 zhuimengzhe 来自江苏省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤
经验分享：主编华人，对国人比较友好，主编和评审专家也非常负责，分不高，但也不水，希望期刊越办越好吧

63 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2254583, encodeId=91582254583cd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：主编华人，对国人比较友好，主编和评审专家也非常负责，分不高，但也不水，希望期刊越办越好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Tue Mar 04 21:40:32 CST 2025, time=2025-03-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131524, encodeId=869021315241d, content=3.12投稿的，至今已2个月了，状态从未改变。有啥建议吗？可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu May 11 07:20:15 CST 2023, time=2023-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117027, encodeId=1973211e027d7, content=这个是纯开源的杂志吗，费用多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5026441235, createdName=ms1000000232937298, createdTime=Wed Mar 01 11:33:26 CST 2023, time=2023-03-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113822, encodeId=9602211382224, content=有人投过综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 09 17:10:11 CST 2023, time=2023-02-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1071848, encodeId=545710e184814, content=经验分享：历时2个月顺利接收，非常感谢网友老师的热心回复，很有帮助。我的经验也是借鉴的平台上前辈们的简易。中国本土医学研究的文章，在这个期刊的确比较容易接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=一转身的距离, createdTime=Fri Nov 19 19:22:28 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229142, encodeId=75bc122914263, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021.11转投，2022.5接受，中间返修2次，3个审稿人和编辑都比较负责。其中一个审稿人意见不好，但也给了argue的机会。虽然看到2021IF跌到1点分了，但还是希望杂志越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70392090263, createdName=1591f428e7m, createdTime=Tue Jun 28 13:33:48 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069851, encodeId=6f291069851dd, content=是的，这个期刊投中国的本土研究室比较容易投稿成功。8月中投了一篇，现在已经过了初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=LAH9, createdTime=Sat Nov 13 10:49:36 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203783, encodeId=d38e1203e83a8, content=为什么投稿后会被执行编辑退回呢？是格式不对吗？有知道的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Fri Mar 18 14:00:25 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195808, encodeId=11fe1195808fb, content=投了三个月都没有消息，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Mon Feb 21 20:02:22 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113668, encodeId=9477111366824, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-05-11 ms7000002110969436 来自江苏省

3.12投稿的，至今已2个月了，状态从未改变。有啥建议吗？可以催稿吗？

126 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2254583, encodeId=91582254583cd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：主编华人，对国人比较友好，主编和评审专家也非常负责，分不高，但也不水，希望期刊越办越好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Tue Mar 04 21:40:32 CST 2025, time=2025-03-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131524, encodeId=869021315241d, content=3.12投稿的，至今已2个月了，状态从未改变。有啥建议吗？可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu May 11 07:20:15 CST 2023, time=2023-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117027, encodeId=1973211e027d7, content=这个是纯开源的杂志吗，费用多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5026441235, createdName=ms1000000232937298, createdTime=Wed Mar 01 11:33:26 CST 2023, time=2023-03-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113822, encodeId=9602211382224, content=有人投过综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 09 17:10:11 CST 2023, time=2023-02-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1071848, encodeId=545710e184814, content=经验分享：历时2个月顺利接收，非常感谢网友老师的热心回复，很有帮助。我的经验也是借鉴的平台上前辈们的简易。中国本土医学研究的文章，在这个期刊的确比较容易接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=一转身的距离, createdTime=Fri Nov 19 19:22:28 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229142, encodeId=75bc122914263, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021.11转投，2022.5接受，中间返修2次，3个审稿人和编辑都比较负责。其中一个审稿人意见不好，但也给了argue的机会。虽然看到2021IF跌到1点分了，但还是希望杂志越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70392090263, createdName=1591f428e7m, createdTime=Tue Jun 28 13:33:48 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069851, encodeId=6f291069851dd, content=是的，这个期刊投中国的本土研究室比较容易投稿成功。8月中投了一篇，现在已经过了初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=LAH9, createdTime=Sat Nov 13 10:49:36 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203783, encodeId=d38e1203e83a8, content=为什么投稿后会被执行编辑退回呢？是格式不对吗？有知道的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Fri Mar 18 14:00:25 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195808, encodeId=11fe1195808fb, content=投了三个月都没有消息，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Mon Feb 21 20:02:22 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113668, encodeId=9477111366824, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-03-01 ms1000000232937298 来自江苏省

这个是纯开源的杂志吗，费用多少

153 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2254583, encodeId=91582254583cd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：主编华人，对国人比较友好，主编和评审专家也非常负责，分不高，但也不水，希望期刊越办越好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Tue Mar 04 21:40:32 CST 2025, time=2025-03-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131524, encodeId=869021315241d, content=3.12投稿的，至今已2个月了，状态从未改变。有啥建议吗？可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu May 11 07:20:15 CST 2023, time=2023-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117027, encodeId=1973211e027d7, content=这个是纯开源的杂志吗，费用多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5026441235, createdName=ms1000000232937298, createdTime=Wed Mar 01 11:33:26 CST 2023, time=2023-03-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113822, encodeId=9602211382224, content=有人投过综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 09 17:10:11 CST 2023, time=2023-02-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1071848, encodeId=545710e184814, content=经验分享：历时2个月顺利接收，非常感谢网友老师的热心回复，很有帮助。我的经验也是借鉴的平台上前辈们的简易。中国本土医学研究的文章，在这个期刊的确比较容易接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=一转身的距离, createdTime=Fri Nov 19 19:22:28 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229142, encodeId=75bc122914263, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021.11转投，2022.5接受，中间返修2次，3个审稿人和编辑都比较负责。其中一个审稿人意见不好，但也给了argue的机会。虽然看到2021IF跌到1点分了，但还是希望杂志越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70392090263, createdName=1591f428e7m, createdTime=Tue Jun 28 13:33:48 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069851, encodeId=6f291069851dd, content=是的，这个期刊投中国的本土研究室比较容易投稿成功。8月中投了一篇，现在已经过了初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=LAH9, createdTime=Sat Nov 13 10:49:36 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203783, encodeId=d38e1203e83a8, content=为什么投稿后会被执行编辑退回呢？是格式不对吗？有知道的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Fri Mar 18 14:00:25 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195808, encodeId=11fe1195808fb, content=投了三个月都没有消息，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Mon Feb 21 20:02:22 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113668, encodeId=9477111366824, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-02-09 ms6000000603665223 来自广东省

有人投过综述吗

0 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2254583, encodeId=91582254583cd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：主编华人，对国人比较友好，主编和评审专家也非常负责，分不高，但也不水，希望期刊越办越好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Tue Mar 04 21:40:32 CST 2025, time=2025-03-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131524, encodeId=869021315241d, content=3.12投稿的，至今已2个月了，状态从未改变。有啥建议吗？可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu May 11 07:20:15 CST 2023, time=2023-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117027, encodeId=1973211e027d7, content=这个是纯开源的杂志吗，费用多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5026441235, createdName=ms1000000232937298, createdTime=Wed Mar 01 11:33:26 CST 2023, time=2023-03-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113822, encodeId=9602211382224, content=有人投过综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 09 17:10:11 CST 2023, time=2023-02-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1071848, encodeId=545710e184814, content=经验分享：历时2个月顺利接收，非常感谢网友老师的热心回复，很有帮助。我的经验也是借鉴的平台上前辈们的简易。中国本土医学研究的文章，在这个期刊的确比较容易接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=一转身的距离, createdTime=Fri Nov 19 19:22:28 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229142, encodeId=75bc122914263, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021.11转投，2022.5接受，中间返修2次，3个审稿人和编辑都比较负责。其中一个审稿人意见不好，但也给了argue的机会。虽然看到2021IF跌到1点分了，但还是希望杂志越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70392090263, createdName=1591f428e7m, createdTime=Tue Jun 28 13:33:48 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069851, encodeId=6f291069851dd, content=是的，这个期刊投中国的本土研究室比较容易投稿成功。8月中投了一篇，现在已经过了初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=LAH9, createdTime=Sat Nov 13 10:49:36 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203783, encodeId=d38e1203e83a8, content=为什么投稿后会被执行编辑退回呢？是格式不对吗？有知道的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Fri Mar 18 14:00:25 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195808, encodeId=11fe1195808fb, content=投了三个月都没有消息，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Mon Feb 21 20:02:22 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113668, encodeId=9477111366824, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-11-19 一转身的距离

经验分享：历时2个月顺利接收，非常感谢网友老师的热心回复，很有帮助。我的经验也是借鉴的平台上前辈们的简易。中国本土医学研究的文章，在这个期刊的确比较容易接受。

226 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2254583, encodeId=91582254583cd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：主编华人，对国人比较友好，主编和评审专家也非常负责，分不高，但也不水，希望期刊越办越好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Tue Mar 04 21:40:32 CST 2025, time=2025-03-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131524, encodeId=869021315241d, content=3.12投稿的，至今已2个月了，状态从未改变。有啥建议吗？可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu May 11 07:20:15 CST 2023, time=2023-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117027, encodeId=1973211e027d7, content=这个是纯开源的杂志吗，费用多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5026441235, createdName=ms1000000232937298, createdTime=Wed Mar 01 11:33:26 CST 2023, time=2023-03-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113822, encodeId=9602211382224, content=有人投过综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 09 17:10:11 CST 2023, time=2023-02-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1071848, encodeId=545710e184814, content=经验分享：历时2个月顺利接收，非常感谢网友老师的热心回复，很有帮助。我的经验也是借鉴的平台上前辈们的简易。中国本土医学研究的文章，在这个期刊的确比较容易接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=一转身的距离, createdTime=Fri Nov 19 19:22:28 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229142, encodeId=75bc122914263, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021.11转投，2022.5接受，中间返修2次，3个审稿人和编辑都比较负责。其中一个审稿人意见不好，但也给了argue的机会。虽然看到2021IF跌到1点分了，但还是希望杂志越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70392090263, createdName=1591f428e7m, createdTime=Tue Jun 28 13:33:48 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069851, encodeId=6f291069851dd, content=是的，这个期刊投中国的本土研究室比较容易投稿成功。8月中投了一篇，现在已经过了初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=LAH9, createdTime=Sat Nov 13 10:49:36 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203783, encodeId=d38e1203e83a8, content=为什么投稿后会被执行编辑退回呢？是格式不对吗？有知道的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Fri Mar 18 14:00:25 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195808, encodeId=11fe1195808fb, content=投了三个月都没有消息，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Mon Feb 21 20:02:22 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113668, encodeId=9477111366824, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-06-28 1591f428e7m

审稿速度:6.0 | 投稿命中率:50.0
经验分享：2021.11转投，2022.5接受，中间返修2次，3个审稿人和编辑都比较负责。其中一个审稿人意见不好，但也给了argue的机会。虽然看到2021IF跌到1点分了，但还是希望杂志越办越好。

169 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2254583, encodeId=91582254583cd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：主编华人，对国人比较友好，主编和评审专家也非常负责，分不高，但也不水，希望期刊越办越好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Tue Mar 04 21:40:32 CST 2025, time=2025-03-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131524, encodeId=869021315241d, content=3.12投稿的，至今已2个月了，状态从未改变。有啥建议吗？可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu May 11 07:20:15 CST 2023, time=2023-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117027, encodeId=1973211e027d7, content=这个是纯开源的杂志吗，费用多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5026441235, createdName=ms1000000232937298, createdTime=Wed Mar 01 11:33:26 CST 2023, time=2023-03-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113822, encodeId=9602211382224, content=有人投过综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 09 17:10:11 CST 2023, time=2023-02-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1071848, encodeId=545710e184814, content=经验分享：历时2个月顺利接收，非常感谢网友老师的热心回复，很有帮助。我的经验也是借鉴的平台上前辈们的简易。中国本土医学研究的文章，在这个期刊的确比较容易接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=一转身的距离, createdTime=Fri Nov 19 19:22:28 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229142, encodeId=75bc122914263, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021.11转投，2022.5接受，中间返修2次，3个审稿人和编辑都比较负责。其中一个审稿人意见不好，但也给了argue的机会。虽然看到2021IF跌到1点分了，但还是希望杂志越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70392090263, createdName=1591f428e7m, createdTime=Tue Jun 28 13:33:48 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069851, encodeId=6f291069851dd, content=是的，这个期刊投中国的本土研究室比较容易投稿成功。8月中投了一篇，现在已经过了初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=LAH9, createdTime=Sat Nov 13 10:49:36 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203783, encodeId=d38e1203e83a8, content=为什么投稿后会被执行编辑退回呢？是格式不对吗？有知道的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Fri Mar 18 14:00:25 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195808, encodeId=11fe1195808fb, content=投了三个月都没有消息，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Mon Feb 21 20:02:22 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113668, encodeId=9477111366824, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-11-13 LAH9

是的，这个期刊投中国的本土研究室比较容易投稿成功。8月中投了一篇，现在已经过了初审。

227 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2254583, encodeId=91582254583cd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：主编华人，对国人比较友好，主编和评审专家也非常负责，分不高，但也不水，希望期刊越办越好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Tue Mar 04 21:40:32 CST 2025, time=2025-03-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131524, encodeId=869021315241d, content=3.12投稿的，至今已2个月了，状态从未改变。有啥建议吗？可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu May 11 07:20:15 CST 2023, time=2023-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117027, encodeId=1973211e027d7, content=这个是纯开源的杂志吗，费用多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5026441235, createdName=ms1000000232937298, createdTime=Wed Mar 01 11:33:26 CST 2023, time=2023-03-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113822, encodeId=9602211382224, content=有人投过综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 09 17:10:11 CST 2023, time=2023-02-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1071848, encodeId=545710e184814, content=经验分享：历时2个月顺利接收，非常感谢网友老师的热心回复，很有帮助。我的经验也是借鉴的平台上前辈们的简易。中国本土医学研究的文章，在这个期刊的确比较容易接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=一转身的距离, createdTime=Fri Nov 19 19:22:28 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229142, encodeId=75bc122914263, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021.11转投，2022.5接受，中间返修2次，3个审稿人和编辑都比较负责。其中一个审稿人意见不好，但也给了argue的机会。虽然看到2021IF跌到1点分了，但还是希望杂志越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70392090263, createdName=1591f428e7m, createdTime=Tue Jun 28 13:33:48 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069851, encodeId=6f291069851dd, content=是的，这个期刊投中国的本土研究室比较容易投稿成功。8月中投了一篇，现在已经过了初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=LAH9, createdTime=Sat Nov 13 10:49:36 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203783, encodeId=d38e1203e83a8, content=为什么投稿后会被执行编辑退回呢？是格式不对吗？有知道的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Fri Mar 18 14:00:25 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195808, encodeId=11fe1195808fb, content=投了三个月都没有消息，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Mon Feb 21 20:02:22 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113668, encodeId=9477111366824, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-03-18 ms5000001864993277

为什么投稿后会被执行编辑退回呢？是格式不对吗？有知道的吗？

144 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2254583, encodeId=91582254583cd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：主编华人，对国人比较友好，主编和评审专家也非常负责，分不高，但也不水，希望期刊越办越好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Tue Mar 04 21:40:32 CST 2025, time=2025-03-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131524, encodeId=869021315241d, content=3.12投稿的，至今已2个月了，状态从未改变。有啥建议吗？可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu May 11 07:20:15 CST 2023, time=2023-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117027, encodeId=1973211e027d7, content=这个是纯开源的杂志吗，费用多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5026441235, createdName=ms1000000232937298, createdTime=Wed Mar 01 11:33:26 CST 2023, time=2023-03-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113822, encodeId=9602211382224, content=有人投过综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 09 17:10:11 CST 2023, time=2023-02-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1071848, encodeId=545710e184814, content=经验分享：历时2个月顺利接收，非常感谢网友老师的热心回复，很有帮助。我的经验也是借鉴的平台上前辈们的简易。中国本土医学研究的文章，在这个期刊的确比较容易接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=一转身的距离, createdTime=Fri Nov 19 19:22:28 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229142, encodeId=75bc122914263, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021.11转投，2022.5接受，中间返修2次，3个审稿人和编辑都比较负责。其中一个审稿人意见不好，但也给了argue的机会。虽然看到2021IF跌到1点分了，但还是希望杂志越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70392090263, createdName=1591f428e7m, createdTime=Tue Jun 28 13:33:48 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069851, encodeId=6f291069851dd, content=是的，这个期刊投中国的本土研究室比较容易投稿成功。8月中投了一篇，现在已经过了初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=LAH9, createdTime=Sat Nov 13 10:49:36 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203783, encodeId=d38e1203e83a8, content=为什么投稿后会被执行编辑退回呢？是格式不对吗？有知道的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Fri Mar 18 14:00:25 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195808, encodeId=11fe1195808fb, content=投了三个月都没有消息，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Mon Feb 21 20:02:22 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113668, encodeId=9477111366824, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-02-21 124041f5m71(暂无昵称)

投了三个月都没有消息，太慢了

176 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2254583, encodeId=91582254583cd, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：主编华人，对国人比较友好，主编和评审专家也非常负责，分不高，但也不水，希望期刊越办越好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Tue Mar 04 21:40:32 CST 2025, time=2025-03-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131524, encodeId=869021315241d, content=3.12投稿的，至今已2个月了，状态从未改变。有啥建议吗？可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu May 11 07:20:15 CST 2023, time=2023-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117027, encodeId=1973211e027d7, content=这个是纯开源的杂志吗，费用多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5026441235, createdName=ms1000000232937298, createdTime=Wed Mar 01 11:33:26 CST 2023, time=2023-03-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113822, encodeId=9602211382224, content=有人投过综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 09 17:10:11 CST 2023, time=2023-02-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1071848, encodeId=545710e184814, content=经验分享：历时2个月顺利接收，非常感谢网友老师的热心回复，很有帮助。我的经验也是借鉴的平台上前辈们的简易。中国本土医学研究的文章，在这个期刊的确比较容易接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=一转身的距离, createdTime=Fri Nov 19 19:22:28 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229142, encodeId=75bc122914263, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021.11转投，2022.5接受，中间返修2次，3个审稿人和编辑都比较负责。其中一个审稿人意见不好，但也给了argue的机会。虽然看到2021IF跌到1点分了，但还是希望杂志越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70392090263, createdName=1591f428e7m, createdTime=Tue Jun 28 13:33:48 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069851, encodeId=6f291069851dd, content=是的，这个期刊投中国的本土研究室比较容易投稿成功。8月中投了一篇，现在已经过了初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=LAH9, createdTime=Sat Nov 13 10:49:36 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203783, encodeId=d38e1203e83a8, content=为什么投稿后会被执行编辑退回呢？是格式不对吗？有知道的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Fri Mar 18 14:00:25 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195808, encodeId=11fe1195808fb, content=投了三个月都没有消息，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a342455681, createdName=124041f5m71(暂无昵称), createdTime=Mon Feb 21 20:02:22 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113668, encodeId=9477111366824, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-29 小动量

引言需要写什么内容？

0 1 举报

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务